PA Medical News about breast carcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Proceedings of the National Academy of Sciences of the United States of America, 11/04/09

Persson M et al. – The data indicate that the MYB–NFIB fusion is a hallmark of ACC and that deregulation of the expression of MYB and its target genes is a key oncogenic event in the pathogenesis of ACC. The findings also suggest that the gain–of–function activity resulting from the MYB–NFIB fusion is a candidate therapeutic target.